Filing Details

Accession Number:
0000899243-15-003913
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-24 18:14:27
Reporting Period:
2015-08-20
Filing Date:
2015-08-24
Accepted Time:
2015-08-24 18:14:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1459266 Zs Pharma Inc. ZSPH Pharmaceutical Preparations (2834) 263305698
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376194 A Todd Creech C/O Zs Pharma, Inc.
1100 Park Place, Suite 300
San Mateo CA 94063
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-20 20,000 $2.13 20,000 No 4 M Direct
Common Stock Disposition 2015-08-20 20,000 $50.03 0 No 4 S Direct
Common Stock Acquisiton 2015-08-21 50,000 $2.13 50,000 No 4 M Direct
Common Stock Disposition 2015-08-21 50,000 $49.76 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options Disposition 2015-08-20 20,000 $2.13 20,000 $2.13
Common Stock Employee Stock Options Disposition 2015-08-21 50,000 $2.13 50,000 $2.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
260,771 No 4 M Direct
210,771 No 4 M Direct
Footnotes
  1. Mr. Creech sold 50,000 shares of common stock at prices ranging from $49.50 per share to $50.01 per share.
  2. Mr. Creech was granted options to purchase 280,771 shares of common stock at an exercise price of $2.13 per share on August 16, 2013, of which 25% of the shares subject to such option vested on August 12, 2014, the first anniversary of the vesting commencement date, with the remaining 75% of the options vesting monthly in substantially equal installments over the following 36 months, subject to Mr. Creech's continuing to provide services to the company through each vesting date. Mr. Creech exercised 20,000 of such options on August 20, 2015 and 50,000 of such options on August 21, 2015, all at the exercise price of $2.13 per share.